Susanne Stuffers
Fortune : 100 706 $ au 31/05/2026
Fortune : 100 706 $ au 31/05/2026
Susanne Stuffers currently works at p53 Invest, as CEO & Founding Partner from 2018, Arxx Therapeutics AS, as Vice Chairman, and Nykode Therapeutics ASA, as Chairman from 2025.
Dr. Stuffers also formerly worked at Nykode Therapeutics ASA, as Director, Gentian Diagnostics ASA, as Independent Director, EXACT Therapeutics AS, as Director, and Arctic Securities AS, as Lead Analyst from 2015 to 2018.
Dr. Stuffers received her doctorate degree in 2003 from Erasmus University Rotterdam.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/10/2025 | 296 665 ( 0,09% ) | 100 706 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NYKODE THERAPEUTICS | Président | 23/04/2025 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Arctic Securities AS
Arctic Securities AS Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/10/2018 |
| EXACT THERAPEUTICS | Directeur/Membre du Conseil | - |
| GENTIAN DIAGNOSTICS | Directeur/Membre du Conseil | - |
| NYKODE THERAPEUTICS | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Erasmus University Rotterdam
Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arctic Securities AS
Arctic Securities AS Investment Banks/BrokersFinance Provides brokerage services | Finance |
Nykode Therapeutics ASA
Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Gentian Diagnostics ASA
Gentian Diagnostics ASA Medical SpecialtiesHealth Technology Develops and manufactures in-vitro diagnostic products | Health Technology |
EXACT Therapeutics AS
EXACT Therapeutics AS BiotechnologyHealth Technology Develops technology platform for targeted drug delivery | Health Technology |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national